ANGLE (LON:AGL) Shares Up 14.3% – Time to Buy?

Shares of ANGLE plc (LON:AGLGet Free Report) shot up 14.3% on Tuesday . The company traded as high as GBX 12.99 ($0.16) and last traded at GBX 12.58 ($0.16). 1,308,476 shares were traded during mid-day trading, an increase of 96% from the average session volume of 666,717 shares. The stock had previously closed at GBX 11 ($0.14).

Wall Street Analyst Weigh In

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 70 ($0.86) target price on shares of ANGLE in a research note on Thursday, September 26th.

Read Our Latest Analysis on ANGLE

ANGLE Trading Up 13.6 %

The company has a current ratio of 5.19, a quick ratio of 6.18 and a debt-to-equity ratio of 17.22. The firm has a 50-day moving average of GBX 10.51 and a 200 day moving average of GBX 11.24. The stock has a market capitalization of £40.32 million, a price-to-earnings ratio of -178.57 and a beta of 0.22.

ANGLE Company Profile

(Get Free Report)

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.

Recommended Stories

Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.